At the translational level, CDC73 can be targeted and inhibited by miR-182-3p, and its knockdown can reverse the suppressive effects of miR-182-3p inhibitor on the aggressive phenotypes of oral squamous cell carcinoma cells (Guo et al., 2020). This evidence concerns the gene CDC73 and oral cavity squamous cell carcinoma.